What now with screening electrocardiography?

Annals of Internal Medicine

Volumn 155, Issue 6, 2011, Pages

  Lauer, Michael S ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; EDITORIAL; ELECTROCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY OF LIFE; STROKE; SYSTEMATIC REVIEW; NOTE;

CORONARY DISEASE;

EID: 80052930333     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-155-6-201109200-00011     Document Type: Editorial

References (17)

1. Kannel WB, Dawber TR, Kagan A, Revotskie N, Stokes J 3rd. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med. 1961;55:33-50. [PMID: 13751193]
2. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2007;147:783-786. [PMID: 18056662]
3. U.S. Preventive Services Task Force. Screening for Lipid Disorders in Adults. Rockville, MD: U.S. Preventive Services Task Force; 2008. Accessed at www.uspreventiveservicestaskforce.org/uspstf/uspschol.htm on 10 August 2011.
4. Chou R, Arora B, Dana T, Fu R, Walker M, Humphrey L. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011; 155:375-385.
5. U.S. Preventive Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med. 2004;140:569-572. [PMID: 15068986]
6. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L; U.S. Preventive Services Task Force. Screening for breast cancer: an update for theU.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-737, W237-42. [PMID: 19920273]
7. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365:395-409. [PMID: 21714641]
8. Fleming C, Whitlock EP, Beil TL, Lederle FA. Screening for abdominal aortic aneurysm: a best-evidence systematic review for the U.S. Preventive ServicesTask Force. Ann Intern Med. 2005;142:203-211. [PMID: 15684209]
9. Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, Isaacs C, et al; PLCO Project Team. Effect of screening on ovarian cancer mortality: the Prostate,Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA. 2011;305:2295-2303. [PMID: 21642681]
10. Woods WG, Gao RN, Shuster JJ, Robison LL, Bernstein M, Weitzman S, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041-1106. [PMID: 11932470]
11. Young LH, Wackers FJ, Chyun DA, Davey JA, Barrett EJ, Taillefer R, et al; DIAD Investigators. Cardiac outcomes after screening forasymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA. 2009;301:1547-1555. [PMID: 19366774]
12. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med. 2006;144:850-855. [PMID: 16754927]
13. Tirziu D, Giordano FJ, Simons M. Cell communications in the heart. Circulation. 2010;122:928-37. [PMID: 20805439]
14. McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, Shioi T, et al. Inhibition of mTOR signaling with rapamycin regresses establishedcardiac hypertrophy induced by pressure overload. Circulation. 2004;109: 3050-3055. [PMID: 15184287]
15. Paoletti E, Amidone M, Cassottana P, Gherzi M, Marsano L, Cannella G. Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: a 1-year nonrandomized controlled trial. Am J Kidney Dis. 2008;52:324-3230. [PMID: 18585837]
16. Turka LA, Caplan A. What is the evidence for our standards of care? J Clin Invest. 2011;121:2530. [PMID: 21737884]
17. Moretti A, Bellin M, Welling A, Jung CB, Lam JT, Bott-Flugel L, et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med. 2010;363:1397-1409. [PMID: 20660394]